作者: S. M. Holliday , M. D. H. Dobbin
DOI: 10.1136/BMJ.F4495
关键词:
摘要: Freynhagen and colleagues describe the lack of scientific evidence supporting safety effectiveness long term opioids for chronic non-cancer pain.1 Nevertheless, are now most prescribed drug in US, where oxycodone sales reached $3.1bn (£2.08bn; €2.42bn) 2010. The authors state that moderate to severe pain …